BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Wu Z, Liu Y, Zhan Z, Yang L, Wang C, Jiang Q, Ran H, Li P, Wang Z. ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling. J Nanobiotechnology 2022;20:213. [PMID: 35524280 DOI: 10.1186/s12951-022-01435-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu C, Jiang Y, Wang H, Zhang Y, Ye Y, Qin H, Gao J, Dan Q, Du L, Liu L, Peng F, Li Y, Tu Y. Arthritic Microenvironment Actuated Nanomotors for Active Rheumatoid Arthritis Therapy. Advanced Science 2022. [DOI: 10.1002/advs.202204881] [Reference Citation Analysis]
2 Duan R, Sun K, Fang F, Wang N, He R, Gao Y, Jing L, Li Y, Gong Z, Yao Y, Luan T, Zhang C, Zhang J, Zhao Y, Xie H, Zhou Y, Teng J, Zhang J, Jia Y. An ischemia-homing bioengineered nano-scavenger for specifically alleviating multiple pathogeneses in ischemic stroke. J Nanobiotechnology 2022;20:397. [PMID: 36045405 DOI: 10.1186/s12951-022-01602-7] [Reference Citation Analysis]
3 Wang Y, Wei J, Deng H, Zheng L, Yang H, Lv X. The Role of Nrf2 in Pulmonary Fibrosis: Molecular Mechanisms and Treatment Approaches. Antioxidants 2022;11:1685. [DOI: 10.3390/antiox11091685] [Reference Citation Analysis]